Itay Perlstein

711 total citations
25 papers, 537 citations indexed

About

Itay Perlstein is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Itay Perlstein has authored 25 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in Itay Perlstein's work include Cardiac electrophysiology and arrhythmias (5 papers), Heart Rate Variability and Autonomic Control (5 papers) and Advanced Chemical Sensor Technologies (4 papers). Itay Perlstein is often cited by papers focused on Cardiac electrophysiology and arrhythmias (5 papers), Heart Rate Variability and Autonomic Control (5 papers) and Advanced Chemical Sensor Technologies (4 papers). Itay Perlstein collaborates with scholars based in Israel, United States and United Kingdom. Itay Perlstein's co-authors include Tony G. Johnson, Andrew N. Billin, Christine Massien, Timothy M. Willson, Greg Pearce, Nicolas Ancellin, David C. Lobe, David G. Hassall, Scott D. Patterson and Dennis L. Sprecher and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Itay Perlstein

23 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Itay Perlstein Israel 12 266 141 104 86 68 25 537
Elke Schüler Germany 11 115 0.4× 175 1.2× 211 2.0× 75 0.9× 41 0.6× 13 473
Paul Coats United Kingdom 13 159 0.6× 104 0.7× 67 0.6× 123 1.4× 180 2.6× 28 478
Jiahui Liu China 10 70 0.3× 66 0.5× 47 0.5× 79 0.9× 48 0.7× 45 341
Daniel Jakubik Poland 14 309 1.2× 123 0.9× 38 0.4× 57 0.7× 61 0.9× 20 624
Zoltán Káposzta United Kingdom 9 135 0.5× 179 1.3× 97 0.9× 48 0.6× 98 1.4× 14 508
Yoichi Miwa Japan 12 125 0.5× 242 1.7× 55 0.5× 158 1.8× 161 2.4× 18 545
Glenn J. Smits United States 15 192 0.7× 213 1.5× 48 0.5× 61 0.7× 93 1.4× 25 725
Akira Oshita Japan 13 143 0.5× 232 1.6× 140 1.3× 187 2.2× 50 0.7× 38 621
Kota Suzuki Japan 17 265 1.0× 285 2.0× 55 0.5× 148 1.7× 84 1.2× 45 776
Akira Kato Japan 13 176 0.7× 48 0.3× 41 0.4× 95 1.1× 141 2.1× 32 617

Countries citing papers authored by Itay Perlstein

Since Specialization
Citations

This map shows the geographic impact of Itay Perlstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itay Perlstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itay Perlstein more than expected).

Fields of papers citing papers by Itay Perlstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itay Perlstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itay Perlstein. The network helps show where Itay Perlstein may publish in the future.

Co-authorship network of co-authors of Itay Perlstein

This figure shows the co-authorship network connecting the top 25 collaborators of Itay Perlstein. A scholar is included among the top collaborators of Itay Perlstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itay Perlstein. Itay Perlstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
LeWitt, Peter A., Fabrizio Stocchi, David Arkadir, et al.. (2022). The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program. Frontiers in Neurology. 13. 1036068–1036068. 21 indexed citations
5.
Perlstein, Itay, Roberto Goméni, Michael Lamson, et al.. (2022). Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone. Clinical Pharmacology in Drug Development. 11(7). 865–877. 8 indexed citations
7.
Song, Yuanlin, Zhaoqing Wang, Itay Perlstein, et al.. (2017). Reversal of apixaban anticoagulation by four‐factor prothrombin complex concentrates in healthy subjects: a randomized three‐period crossover study. Journal of Thrombosis and Haemostasis. 15(11). 2125–2137. 39 indexed citations
8.
Song, Yan, Xiaoli Wang, Itay Perlstein, et al.. (2015). Relative Bioavailability of Apixaban Solution or Crushed Tablet Formulations Administered by Mouth or Nasogastric Tube in Healthy Subjects. Clinical Therapeutics. 37(8). 1703–1712. 25 indexed citations
9.
Perlstein, Itay, Zhaoqing Wang, Yan Song, et al.. (2014). Reversal of Apixaban Anticoagulation By 4-Factor Prothrombin Complex Concentrates in Healthy Subjects. Blood. 124(21). 345–345. 13 indexed citations
10.
Khan, Anis A., Itay Perlstein, & Rajesh Krishna. (2009). The Use of Clinical Utility Assessments in Early Clinical Development. The AAPS Journal. 11(1). 33–38. 11 indexed citations
11.
Perlstein, Itay, James A. Bolognese, Rajesh Krishna, & John A. Wagner. (2009). Evaluation of Agile Designs in First-in-Human (FIH) Trials—A Simulation Study. The AAPS Journal. 11(4). 653–63. 6 indexed citations
12.
Sprecher, Dennis L., Christine Massien, Greg Pearce, et al.. (2006). Triglyceride:High-Density Lipoprotein Cholesterol Effects in Healthy Subjects Administered a Peroxisome Proliferator Activated Receptor δ Agonist. Arteriosclerosis Thrombosis and Vascular Biology. 27(2). 359–365. 164 indexed citations
13.
Perlstein, Itay, Kenneth Ryan, Suzanne DeFelice, et al.. (2005). Posttranslational Control of a Cardiac Ion Channel Transgene In Vivo : Clarithromycin–hMiRP1-Q9E Interactions. Human Gene Therapy. 16(7). 906–910. 17 indexed citations
14.
Perlstein, Itay, Jeanne M. Connolly, Chao Song, et al.. (2003). DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection. Gene Therapy. 10(17). 1420–1428. 68 indexed citations
16.
Perlstein, Itay, David Stepensky, Wojciech Krzyżański, & Amnon Hoffman. (2002). A Signal Transduction Pharmacodynamic Model of the Kinetics of the Parasympathomimetic Activity of Low-Dose Scopolamine and Atropine in Rats. Journal of Pharmaceutical Sciences. 91(12). 2500–2510. 19 indexed citations
17.
Perlstein, Itay, David Stepensky, Dan Sapoznikov, & Amnon Hoffman. (2001). Power Spectral Analysis of Heart Rate Variability in Rats as a Quantitative Tool in the PK-PD Analysis of the Parasympatholytic Activity of Atropine. Pharmaceutical Research. 18(8). 1220–1225. 9 indexed citations
18.
Perlstein, Itay & Amnon Hoffman. (2000). Cumulative plot of heart rate variability spectrum assesses kinetics of action of cholinergic drugs in rats. American Journal of Physiology-Heart and Circulatory Physiology. 279(1). H110–H115. 7 indexed citations
19.
Perlstein, Itay, et al.. (1999). The Effect of Cimetidine on the Pharmacodynamics of Theophylline‐Induced Seizures and Ethanol Hypnotic Activity. Pharmacology & Toxicology. 85(5). 130–132. 2 indexed citations
20.
Backon, Joshua, et al.. (1997). The Anticonvulsant Effect of Deprenyl on Pentylenetetrazol-Induced Seizures in Lewis Rats. International Journal of Neuroscience. 90(3-4). 223–232. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026